Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Alnylam agrees to drop patent lawsuit against Moderna over Covid-19 vaccine
7 months ago
Pharma
Law
J&J discontinues mid-stage dengue study, citing deprioritization of communicable disease work
7 months ago
R&D
Pharma
Editas sells future CRISPR license fees; Plus, news about Oncolytics Biotech
7 months ago
News Briefing
Biotech's third quarter was relatively bright — with a few caveats
7 months ago
Financing
Startups
Sanofi sells rare disease drug Enjaymo to Recordati for $825M upfront
7 months ago
Deals
Pharma
After $14B exit, Karuna co-founder finds next bet; Ex-Regenxbio CEO Ken Mills heads to Tagworks
7 months ago
Peer Review
End of obesity drug shortage threatens patient access to compounded shots that Lilly calls risky
7 months ago
Pharma
Health Tech
UK government proposes phased rollout of Eli Lilly's weight loss drug
7 months ago
Pharma
FDA+
Exclusive: Relay Therapeutics cuts another 10% of company, citing continued streamlining efforts
7 months ago
People
R&D
WuXi companies may sell units impacted by Biosecure — report
7 months ago
Deals
China
FDA's drug center launches new coordinating body for modeling and simulation
7 months ago
FDA+
Novo and Lilly outline plans to mitigate disruptions from US port strikes
7 months ago
Pharma
Manufacturing
Opdivo gets FDA approval for use around lung cancer surgery, following Keytruda and Imfinzi
7 months ago
R&D
FDA+
Pfizer lays off staff in Ireland; Baxter closes NC facility due to hurricane damage
7 months ago
Manufacturing
Flagship partners with key Singapore R&D agency as it boosts APAC investment
7 months ago
Financing
Startups
FDA lifts partial hold on Avidity’s myotonic dystrophy drug; Orum's IPO in South Korea
7 months ago
News Briefing
Eli Lilly resolves shortage for tirzepatide, potentially ending compounders' run
7 months ago
Pharma
Enara Bio’s $32.5M Series B to support lead dark antigen program for GI cancers
7 months ago
Financing
R&D
Investor Kurma Partners raises €140M for latest Europe-focused biotech fund
7 months ago
Financing
Startups
Resolution raises $85M to test macrophage therapies in end-stage liver disease
7 months ago
Financing
Cell/Gene Tx
Septerna files for Nasdaq listing as biotech IPOs come to life
7 months ago
Financing
Startups
For next round of IRA price negotiations, US says it will meet with companies sooner
7 months ago
Pharma
BioNTech opens the hood on its AI ambitions, and they're not just for mRNA
7 months ago
R&D
AI
AstraZeneca, AbbVie, PhRMA lose court battle over Louisiana 340B law
7 months ago
Pharma
FDA+
First page
Previous page
86
87
88
89
90
91
92
Next page
Last page